More paths to PI3Kγ.

More paths to PI3Kγ.

Saved in:

Bibliographic Details
Main Authors:	Len Stephens, Phillip Hawkins
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS Biology
Online Access:	https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.1001594&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Signaling via class IA Phosphoinositide 3-kinases (PI3K) in human, breast-derived cell lines.
by: Veronique Juvin, et al.
Published: (2013-01-01)

Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.
by: Jatinder K Juss, et al.
Published: (2012-01-01)

PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control.
by: Romy Walser, et al.
Published: (2013-01-01)

The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ
by: Wang Xue, et al.
Published: (2019-03-01)

Specific Requirement of the p84/p110γ Complex of PI3Kγ for Antibody‐Activated, Inducible Cross‐Presentation in Murine Type 2 DCs
by: Despoina Koumantou, et al.
Published: (2024-11-01)

Laminin γ-2 (LAMC2) promotes the proliferation and invasion of pancreatic cancer cells by regulating PI3K/Akt signaling
by: Qi Wang, et al.
Published: (2025-03-01)

Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling.
by: Marion Régnier, et al.
Published: (2025-04-01)

Structural insights into isoform-specific RAS-PI3Kα interactions and the role of RAS in PI3Kα activation
by: Daniel Czyzyk, et al.
Published: (2025-01-01)

PI3K/AKT Pathway and Brain Malformations
by: Gavin B. Rice, et al.
Published: (2015-07-01)

PI3Kγ signaling controls trafficking of CD8+ T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model
by: Marialuisa Perrotta, et al.
Published: (2025-07-01)

Depletion of γ-glutamyl cyclotransferase suppresses the proliferation, migration and invasion of breast cancer cells accompanied by the activation of PI3K/AKT/mTOR pathway
by: De He, et al.
Published: (2025-06-01)

PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitors
by: Xu Zhang, et al.
Published: (2025-06-01)

Therapeutic management of PI3Kα inhibitor-induced hyperglycemia with a novel glucokinase activator: Advancing the Frontier of PI3Kα inhibitor therapy
by: Guanqin Jin, et al.
Published: (2025-06-01)

Γ-independent dominating graphs of paths and cycles
by: Roongrat Samanmoo, et al.
Published: (2024-08-01)

PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+ T cell-dependent antitumor immunity and abscopal effect after local irradiation
by: Tae-Jin Kim, et al.
Published: (2022-03-01)

PI3K/Akt in IPF: untangling fibrosis and charting therapies
by: Janki Bhatt, et al.
Published: (2025-03-01)

PI3K/Akt pathway and neuroinflammation in sepsis-associated encephalopathy
by: Guo Yang, et al.
Published: (2025-08-01)

Search for CP violation in D s + → K S 0 K − π + π + $$ {D}_{(s)}^{+}\to {K}_S^0{K}^{-}{\pi}^{+}{\pi}^{+} $$ decays using triple and quadruple products
by: The Belle and Belle II collaborations, et al.
Published: (2025-04-01)

Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/Akt signaling axis
by: XC Zhou, et al.
Published: (2024-07-01)

Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
by: Niklas Gremke, et al.
Published: (2025-03-01)

Dorema Aucheri and exercise training in enhancing PPARγ/mTOR/PI3K gene expression in muscle tissue of hypothyroid mice: experimental approaches using a hypothyroid mouse model
by: Malihe Bakhti, et al.
Published: (2024-12-01)

The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01)

Mesenchymal stem cells targeting PI3K/AKT pathway in leukemic model
by: Esraa S A Ahmed, et al.
Published: (2019-04-01)

The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies
by: Alexa E. Schmitz, et al.
Published: (2025-05-01)

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies
by: Binu Kandathilparambil Sasi, et al.
Published: (2025-06-01)

Wogonin inhibits the proliferation of prolactinoma through the PI3K/AKT signaling pathway
by: Zhiyong Du, et al.
Published: (2025-05-01)

PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment
by: Mingyang Jiang, et al.
Published: (2025-08-01)

138. PI3K Activation Drives Protein Homeostasis Pathology in Venous Malformations
by: Zachary C. LeBlanc, AB, et al.
Published: (2025-05-01)

Pilaralisib inhibits the replication of enteroviruses by targeting the PI3K/AKT signaling pathway
by: Jie Zhou, et al.
Published: (2025-07-01)

Orientin alleviates chondrocyte senescence and osteoarthritis by inhibiting PI3K/AKT pathway
by: Haitao Chen, et al.
Published: (2025-03-01)

PI3K/AKT signaling in parasites and parasite diseases: Role and therapeutic potential
by: Lujun Yan, et al.
Published: (2025-12-01)

Covariation of scleral remodeling and PI3K/Akt signaling pathway in experimental myopia
by: Xiaomeng Li, et al.
Published: (2025-04-01)

Nrf2 negatively regulates melanogenesis by modulating PI3K/Akt signaling.
by: Jung-Min Shin, et al.
Published: (2014-01-01)

EVALUATION OF PTEN AND PI3K/AKT EXPRESSIONS IN STANOZOLOL-TREATED RAT KIDNEYS
by: Tuğba Kotil, et al.
Published: (2022-01-01)

The Mechanisms and Therapeutic Implications of PI3K Signaling in Airway Inflammation and Remodeling in Asthma
by: Song B, et al.
Published: (2025-03-01)

A Dynamic Model of PI3K/AKT Pathways in Acute Myeloid Leukemia
by: Yudi Ari Adi, et al.
Published: (2018-01-01)

Subunit-Specific Developmental Roles of PI3K in SF1-Expressing Cells
by: My Khanh Q. Huynh, et al.
Published: (2024-10-01)

Zmynd11 is essential for neurogenesis by coordinating H3K36me3 modification of Epha2 and PI3K signaling pathway
by: Xu Yang, et al.
Published: (2025-04-01)

Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway
by: Adrish Sen, et al.
Published: (2025-01-01)

Naringenin Targets PI3K p85alpha to Suppress PI3K/AKT Signaling Pathway and Ameliorate Disordered MMP-9 Secretion in Cigarette Smoke Extract-Induced Alveolar Macrophages In Vitro
by: Weiyang Fan, et al.
Published: (2025-05-01)